- No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
7759
TWO
Week ended 14 Aug 2026
Weekly Investor Report
SUNHAWK BIO · Healthcare · Biotechnology
Latest close
29.40 TWD
-1.0%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -21.5% below the Trend Line and sits at 6.6% of its 52-week range. The latest completed week returned -1.0%, after a -6.4% four-week move.
Setup score
21
out of 100
Latest Close
29.40 TWD
14 Aug 2026
1W Return
-1.0%
latest completed week
4W Return
-6.4%
short-term follow-through
12W Return
-20.8%
quarterly tape
Trend Breadth
0.0%
0 of 52 weeks active
Volume Ratio
1.1x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-1.0%
Latest completed week; four-week move -6.4%.
Indicator stack
0/56
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 32.19%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -21.5% below the Trend Line and sits at 6.6% of its 52-week range. The latest completed week returned -1.0%, after a -6.4% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.1x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
14 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0612-week average 0.02
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure4/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.06Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -6.4% over four weeks, -20.8% over 12 weeks, and -59.3% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.03Latest activity-pressure read.
Pressure change79.2%Four-week change in activity pressure.
Leadership-61.44Latest relative-leadership reading.
RS change-1.9%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment-
No current sentiment snapshot is stored.
Patient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-64.8%Distance below the 52-week high.
13-week volatility5.4%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
20 Mar
17 Apr
15 May
12 Jun
10 Jul
14 Aug
Weeks higher8 of 2618 weeks finished lower.
Best week+18.7%Week of 20 Mar.
Worst week-14.0%Week of 6 Mar.
Latest week-1.0%Week of 14 Aug.
Shape of recent returns
Strong gains3
Modest gains5
Flat weeks0
Modest losses12
Sharp losses6
Recent vol5.4%13-week weekly-return volatility.
Base vol5.3%52-week weekly-return volatility.
Up/down split15/37Count of positive and negative weeks in the 52-week window.
Average skew4.2% / -3.9%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorTW Healthcare
4-week rank- / 100
Group average0.1%
Trend breadth34.0%
Trend34.0%active weekly trend signals
MD60.0%positive activity pressure
RS9.0%positive relative leadership
Four-week leaders
IndustryTW Biotechnology
4-week rank70 / 96
Group average-2.7%
Trend breadth24.0%
Trend24.0%active weekly trend signals
MD39.6%positive activity pressure
RS6.2%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape21/100
Trend, activity pressure, participation, and risk combine to a 21/100 tape read.
Indicator analysis16/100Latest 12-week confirmation: trend 0/12, activity pressure 4/12, relative leadership 0/12.
Activity pressure 0.06; No reversal markers Next-Week ExpectancyNegative 32.19%Next-week expectancy is negative with a 32.19% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100No sentiment snapshot is stored yet.
Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 14 Aug 2026 | 29.40 TWD | -1.0% | 37.45 TWD | 64.61 TWD | -0.03 | -61.44 | 221.0K | Off |
| 7 Aug 2026 | 29.70 TWD | 5.7% | 38.44 TWD | 65.09 TWD | -0.04 | -60.72 | 52.4K | Off |
| 31 Jul 2026 | 28.10 TWD | -0.9% | 39.55 TWD | 65.58 TWD | -0.13 | -62.80 | 228.4K | Off |
| 24 Jul 2026 | 28.35 TWD | -9.7% | 40.70 TWD | 66.11 TWD | -0.01 | -63.94 | 179.6K | Off |
| 17 Jul 2026 | 31.40 TWD | 1.8% | 41.93 TWD | 66.65 TWD | -0.15 | -60.27 | 241.8K | Off |
| 10 Jul 2026 | 30.85 TWD | -1.3% | 42.99 TWD | 67.16 TWD | -0.29 | -64.28 | 80.3K | Off |
| 3 Jul 2026 | 31.25 TWD | 7.0% | 43.98 TWD | 67.70 TWD | -0.16 | -66.03 | 385.0K | Off |
| 26 Jun 2026 | 29.20 TWD | -2.5% | 45.11 TWD | 68.24 TWD | -0.14 | -67.66 | 128.0K | Off |
| 19 Jun 2026 | 29.95 TWD | 3.3% | 46.28 TWD | 68.83 TWD | 0.18 | -69.01 | 84.4K | Off |
| 12 Jun 2026 | 29.00 TWD | -3.5% | 47.43 TWD | 69.43 TWD | 0.29 | -69.18 | 297.9K | Off |
| 5 Jun 2026 | 30.05 TWD | -11.5% | 48.68 TWD | 70.06 TWD | 0.25 | -69.54 | 391.3K | Off |
| 29 May 2026 | 33.95 TWD | -8.5% | 49.96 TWD | 70.70 TWD | 0.22 | -66.15 | 242.4K | Off |
| 22 May 2026 | 37.10 TWD | -0.1% | 51.14 TWD | 71.29 TWD | 0.17 | -62.09 | 67.5K | Off |
| 15 May 2026 | 37.15 TWD | -1.2% | 52.22 TWD | 71.85 TWD | 0.06 | -62.39 | 59.9K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.